Activation of NF-κB mediates the PMA-induced differentiation of K562 cells

Cancer Letters

Volumn 132, Issue 1-2, 1998, Pages 99-106

  Kang, Chi Dug ^a   Han, Chang Sup ^b   Kim, Kwang Woon ^b   Do, In Rok ^b   Kim, Cheol Min ^b   Kim, Sun Hee ^a   Lee, Eun Yup ^a,b   Chung, Byung Seon ^b  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

K562; MAP kinase; Megakaryocytic differentiation; NF B; PMA

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGONUCLEOTIDE; CARCINOGEN; ENZYME INHIBITOR; FLAVONOID; PROTEIN KINASE (CALCIUM,CALMODULIN);

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN K 562; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEGAKARYOCYTE; PRIORITY JOURNAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOGENS; CELL DIFFERENTIATION; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; NF-KAPPA B; OLIGONUCLEOTIDES, ANTISENSE; TETRADECANOYLPHORBOL ACETATE;

EID: 0032561086     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00165-7     Document Type: Article

References (28)

1. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1997;1066-1071.
2. Grilli M., Chiu J.J., Lenardo M.J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1993;1-62.
3. Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., Baldwin A.S.J. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1992;1899-1913.
4. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S.J. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell. Biol. 13:1993;3301-3310.
5. Cordle S.R., Donald R., Read M.A., Hawiger J. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:1993;11803-11810.
6. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben Neriah Y., Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 365:1993;182-185.
7. Rice N.R., Ernst M.K. In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12:1993;4685-4695.
8. Sun S.C., Elwood J., Beraud C., Greene W.C. Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:1994;7377-7384.
9. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45:1975;321-334.
10. Sutherland J.A., Turner A.R., Mannoni P., McGann L.E., Turc J.M. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J. Biol. Response Mod. 5:1986;250-262.
11. Tabilio A., Pelicci P.G., Vinci G., Mannoni P., Civin C.I., Vainchenker W., Testa U., Lipinski M., Rochant H., Breton Gorius J. Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res. 43:1983;4569-4574.
12. Tetteroo P.A., Massaro F., Mulder A., Schreuder van Gelder R., von dem Borne A.E. Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk. Res. 8:1984;197-206.
13. Kang C.D., Lee B.K., Kim K.W., Kim C.M., Kim S.H., Chung B.S. Signaling mechanism of PMA-induced differentiation of K562 cells. Biochem. Biophys. Res. Commun. 221:1996;95-100.
14. Kieran M., Blank V., Logeat F., Vandekerckhove J., Lottspeich F., Le Bail O., Urban M.B., Kourilsky P., Baeuerle P.A., Israel A. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1990;1007-1018.
15. Schmitz M.L., Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10:1991;3805-3817.
16. C.L. Dent, D.S. Latchmann, in: D.S. Latchmann (Ed.), Transcription Factors: A Practical Approach, IRL Press, 1993, pp. 10-12.
17. Lenardo M.J., Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
18. Sokoloski J.A., Sartorelli A.C., Rosen C.A., Narayanan R. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood. 82:1993;625-632.
19. Whalen A.M., Galasinski S.C., Shapiro P.S., Nahreini T.S., Ahn N.G. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase. Mol. Cell. Biol. 17:1997;1947-1958.
20. Herrera R., Hubbell S., Decker S., Petruzzelli L. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp. Cell Res. 238:1998;407-414.
21. Racke F.K., Lewandowska K., Goueli S., Goldfarb A.N. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J. Biol. Chem. 272:1997;23366-23370.
22. Gewirtz A.M., Burger D., Rado T.A., Benz E.J. Jr., Hoffman R. Constitutive expression of platelet glycoproteins by the human leukemia cell line K562. Blood. 60:1982;785-789.
23. Vainchenker W., Testa U., Guichard J., Titeux M., Breton Gorius J. Heterogeneity in the cellular commitment of a human leukemic cell line: K 562. Blood Cells. 7:1981;357-375.
24. Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. USA. 90:1993;2532-2536.
25. Sun S.C., Ganchi P.A., Ballard D.W., Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 259:1993;1912-1915.
26. Le Bail O., Schmidt-Ullrich R., Israel A. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 12:1993;5043-5049.
27. Ghoda L., Lin X., Greene W.C. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro. J. Biol. Chem. 272:1997;21281-21288.
28. Schouten G.J., Vertegaal A.C., Whiteside S.T., Israel A., Toebes M., Dorsman J.C., van der Eb A.J., Zantema A. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:1997;3133-3144.